Cardax Inc banner

Intrinsic Value

CDXI doesn't have a meaningful market cap.
Not Available for CDXI

There is not enough data to reliably calculate the intrinsic value for Cardax Inc.

Do our valuations actually work? See backtest results .

Alternatives to CDXI

Fundamental Analysis

What Cardax Does

Pharmaceuticals Health Care

Cardax, Inc. is a development stage biopharmaceutical company, which engages in development of pharmaceuticals for chronic diseases driven by inflammation. The company is headquartered in Honolulu, Hawaii and currently employs 10 full-time employees. The company went IPO on 2012-01-30. The firm markets ZanthoSyn, an astaxanthin dietary supplement for lifespan and health span (inflammatory health), including joint and muscle function, cognitive performance, and cardiovascular health.

Headquarters
United States of America US
Employees
10
IPO date
Jan 30, 2012
Read the full company overview
View Company Overview
Financials

Revenue & Expenses Breakdown
Cardax Inc

Efficiency

Earnings Waterfall
Cardax Inc

Wall St Price Targets

Capital Returns

Competitive Landscape